EA039037B1 - Рекомбинантный поксвирус для усиления врожденного иммунного ответа у позвоночного и его применение - Google Patents

Info

Publication number

EA039037B1

EA039037B1 EA201691120A EA201691120A EA039037B1 EA 039037 B1 EA039037 B1 EA 039037B1 EA 201691120 A EA201691120 A EA 201691120A EA 201691120 A EA201691120 A EA 201691120A EA 039037 B1 EA039037 B1 EA 039037B1

Authority

EA

Eurasian Patent Office

Prior art keywords

ifn

mva

virus

cells

protein

Prior art date

2013-11-28

Links

• Espacenet
• Global Dossier
• Discuss

• 230000015788 innate immune response Effects 0.000 title claims abstract description 20
• 241000251539 Vertebrata <Metazoa> Species 0.000 title claims abstract description 18
• 230000002708 enhancing effect Effects 0.000 title claims abstract description 11
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims abstract description 153
• 102000040650 (ribonucleotides)n+m Human genes 0.000 claims abstract description 120
• 208000015181 infectious disease Diseases 0.000 claims abstract description 86
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 80
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 61
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 61
• 238000000034 method Methods 0.000 claims abstract description 34
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 30
• 230000002163 immunogen Effects 0.000 claims abstract description 23
• 108090000467 Interferon-beta Proteins 0.000 claims description 143
• 102100026720 Interferon beta Human genes 0.000 claims description 136
• 108091007433 antigens Proteins 0.000 claims description 119
• 239000000427 antigen Substances 0.000 claims description 118
• 102000036639 antigens Human genes 0.000 claims description 118
• 241000700605 Viruses Species 0.000 claims description 111
• 108090000623 proteins and genes Proteins 0.000 claims description 103
• 108020004999 messenger RNA Proteins 0.000 claims description 85
• 230000001965 increasing effect Effects 0.000 claims description 71
• 102000004169 proteins and genes Human genes 0.000 claims description 57
• 238000013518 transcription Methods 0.000 claims description 50
• 230000035897 transcription Effects 0.000 claims description 50
• 108700026244 Open Reading Frames Proteins 0.000 claims description 45
• 241000700618 Vaccinia virus Species 0.000 claims description 39
• 230000000295 complement effect Effects 0.000 claims description 39
• 230000003612 virological effect Effects 0.000 claims description 39
• 102000006992 Interferon-alpha Human genes 0.000 claims description 37
• 108010047761 Interferon-alpha Proteins 0.000 claims description 36
• 238000004519 manufacturing process Methods 0.000 claims description 34
• OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 claims description 27
• 230000028327 secretion Effects 0.000 claims description 26
• 102000004127 Cytokines Human genes 0.000 claims description 25
• 108090000695 Cytokines Proteins 0.000 claims description 25
• 239000003184 complementary RNA Substances 0.000 claims description 22
• 108020004394 Complementary RNA Proteins 0.000 claims description 19
• 241000700629 Orthopoxvirus Species 0.000 claims description 19
• 125000003729 nucleotide group Chemical group 0.000 claims description 19
• 239000002773 nucleotide Substances 0.000 claims description 18
• 206010028980 Neoplasm Diseases 0.000 claims description 16
• 230000001580 bacterial effect Effects 0.000 claims description 16
• 108010012236 Chemokines Proteins 0.000 claims description 15
• 102000019034 Chemokines Human genes 0.000 claims description 15
• 230000000139 costimulatory effect Effects 0.000 claims description 12
• 241000700560 Molluscum contagiosum virus Species 0.000 claims description 11
• 102000003810 Interleukin-18 Human genes 0.000 claims description 10
• 108090000171 Interleukin-18 Proteins 0.000 claims description 10
• 206010046865 Vaccinia virus infection Diseases 0.000 claims description 10
• 230000002538 fungal effect Effects 0.000 claims description 10
• 208000007089 vaccinia Diseases 0.000 claims description 10
• 102000004889 Interleukin-6 Human genes 0.000 claims description 9
• 108090001005 Interleukin-6 Proteins 0.000 claims description 9
• 241000700665 Sheeppox virus Species 0.000 claims description 9
• 239000003937 drug carrier Substances 0.000 claims description 9
• 241000700663 Avipoxvirus Species 0.000 claims description 8
• 102000002227 Interferon Type I Human genes 0.000 claims description 8
• 108010014726 Interferon Type I Proteins 0.000 claims description 8
• VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims description 8
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 8
• 102100021943 C-C motif chemokine 2 Human genes 0.000 claims description 7
• 102100032367 C-C motif chemokine 5 Human genes 0.000 claims description 7
• 102100034221 Growth-regulated alpha protein Human genes 0.000 claims description 7
• 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 claims description 7
• 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims description 7
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 claims description 7
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 claims description 7
• 241000700627 Monkeypox virus Species 0.000 claims description 7
• 108010074328 Interferon-gamma Proteins 0.000 claims description 6
• 102100037850 Interferon gamma Human genes 0.000 claims description 5
• 241000700563 Leporipoxvirus Species 0.000 claims description 4
• 241000700639 Parapoxvirus Species 0.000 claims description 4
• 241001455646 Buffalopox virus Species 0.000 claims description 3
• 241000700622 Vaccinia virus Copenhagen Species 0.000 claims description 3
• 241000921938 Mule deerpox virus Species 0.000 claims description 2
• 241000036581 Vaccinia virus Western Reserve Species 0.000 claims description 2
• 108010084313 CD58 Antigens Proteins 0.000 claims 1
• 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 claims 1
• 241000700648 Vaccinia virus Lister Species 0.000 claims 1
• 206010072219 Mevalonic aciduria Diseases 0.000 description 171
• 210000004027 cell Anatomy 0.000 description 149
• 241001183012 Modified Vaccinia Ankara virus Species 0.000 description 124
• 230000006698 induction Effects 0.000 description 67
• 102100034170 Interferon-induced, double-stranded RNA-activated protein kinase Human genes 0.000 description 53
• 101710089751 Interferon-induced, double-stranded RNA-activated protein kinase Proteins 0.000 description 53
• 108010048367 enhanced green fluorescent protein Proteins 0.000 description 46
• 241000699670 Mus sp. Species 0.000 description 45
• 102000014150 Interferons Human genes 0.000 description 38
• 108010050904 Interferons Proteins 0.000 description 38
• 239000013598 vector Substances 0.000 description 37
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 36
• 230000014509 gene expression Effects 0.000 description 36
• 201000010099 disease Diseases 0.000 description 33
• 229940047124 interferons Drugs 0.000 description 32
• 241000282414 Homo sapiens Species 0.000 description 30
• 210000001744 T-lymphocyte Anatomy 0.000 description 28
• 108020004414 DNA Proteins 0.000 description 26
• 229960005486 vaccine Drugs 0.000 description 26
• 230000004913 activation Effects 0.000 description 24
• 150000001413 amino acids Chemical class 0.000 description 22
• 210000004436 artificial bacterial chromosome Anatomy 0.000 description 22
• 239000000203 mixture Substances 0.000 description 21
• 102000005962 receptors Human genes 0.000 description 21
• 108020003175 receptors Proteins 0.000 description 21
• 210000004443 dendritic cell Anatomy 0.000 description 20
• 108091028043 Nucleic acid sequence Proteins 0.000 description 19
• 125000003275 alpha amino acid group Chemical group 0.000 description 19
• 230000010076 replication Effects 0.000 description 19
• 238000012217 deletion Methods 0.000 description 18
• 230000037430 deletion Effects 0.000 description 18
• 239000007924 injection Substances 0.000 description 18
• 238000002347 injection Methods 0.000 description 18
• 238000002255 vaccination Methods 0.000 description 18
• 230000000692 anti-sense effect Effects 0.000 description 17
• 230000001419 dependent effect Effects 0.000 description 17
• 241001529936 Murinae Species 0.000 description 16
• 229920001184 polypeptide Polymers 0.000 description 16
• 102000004196 processed proteins & peptides Human genes 0.000 description 16
• 108090000765 processed proteins & peptides Proteins 0.000 description 16
• 241000700647 Variola virus Species 0.000 description 15
• 241000699666 Mus <mouse, genus> Species 0.000 description 14
• 210000002950 fibroblast Anatomy 0.000 description 14
• 101150039990 B13R gene Proteins 0.000 description 13
• 241000711408 Murine respirovirus Species 0.000 description 13
• 230000002238 attenuated effect Effects 0.000 description 13
• 201000001441 melanoma Diseases 0.000 description 13
• 101100232885 Cowpox virus (strain Brighton Red) CPXV209 gene Proteins 0.000 description 12
• 101100004091 Vaccinia virus (strain Copenhagen) B15R gene Proteins 0.000 description 12
• 101100340726 Vaccinia virus (strain Western Reserve) VACWR197 gene Proteins 0.000 description 12
• 239000012634 fragment Substances 0.000 description 12
• 230000028993 immune response Effects 0.000 description 12
• 230000001404 mediated effect Effects 0.000 description 12
• 239000011550 stock solution Substances 0.000 description 12
• 101150091263 E3L gene Proteins 0.000 description 11
• 210000000265 leukocyte Anatomy 0.000 description 11
• 210000004072 lung Anatomy 0.000 description 11
• 230000037452 priming Effects 0.000 description 11
• 108020005544 Antisense RNA Proteins 0.000 description 10
• 208000035473 Communicable disease Diseases 0.000 description 10
• 241000287828 Gallus gallus Species 0.000 description 10
• 241001465754 Metazoa Species 0.000 description 10
• 210000003719 b-lymphocyte Anatomy 0.000 description 10
• 210000004970 cd4 cell Anatomy 0.000 description 10
• 230000000875 corresponding effect Effects 0.000 description 10
• 238000002474 experimental method Methods 0.000 description 10
• 238000003757 reverse transcription PCR Methods 0.000 description 10
• 101150098466 rpsL gene Proteins 0.000 description 10
• 230000004936 stimulating effect Effects 0.000 description 10
• 239000006228 supernatant Substances 0.000 description 10
• -1 ΓΕ-1β Proteins 0.000 description 10
• NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 9
• 101150095960 B19R gene Proteins 0.000 description 9
• 102000008235 Toll-Like Receptor 9 Human genes 0.000 description 9
• 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 9
• 238000004458 analytical method Methods 0.000 description 9
• 230000006870 function Effects 0.000 description 9
• 210000005260 human cell Anatomy 0.000 description 9
• 102000007863 pattern recognition receptors Human genes 0.000 description 9
• 108010089193 pattern recognition receptors Proteins 0.000 description 9
• 230000004044 response Effects 0.000 description 9
• 238000006467 substitution reaction Methods 0.000 description 9
• 210000001519 tissue Anatomy 0.000 description 9
• 241000588724 Escherichia coli Species 0.000 description 8
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
• 239000002671 adjuvant Substances 0.000 description 8
• 230000007423 decrease Effects 0.000 description 8
• 230000000694 effects Effects 0.000 description 8
• 206010016629 fibroma Diseases 0.000 description 8
• 230000005934 immune activation Effects 0.000 description 8
• 210000002865 immune cell Anatomy 0.000 description 8
• 244000045947 parasite Species 0.000 description 8
• 201000006082 Chickenpox Diseases 0.000 description 7
• 241000700628 Chordopoxvirinae Species 0.000 description 7
• 101100072149 Drosophila melanogaster eIF2alpha gene Proteins 0.000 description 7
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 7
• 108091029795 Intergenic region Proteins 0.000 description 7
• 241000124008 Mammalia Species 0.000 description 7
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 7
• 102100038358 Prostate-specific antigen Human genes 0.000 description 7
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
• 206010046980 Varicella Diseases 0.000 description 7
• 230000003321 amplification Effects 0.000 description 7
• 230000001413 cellular effect Effects 0.000 description 7
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 7
• 230000001939 inductive effect Effects 0.000 description 7
• 238000003199 nucleic acid amplification method Methods 0.000 description 7
• 239000002245 particle Substances 0.000 description 7
• 230000037361 pathway Effects 0.000 description 7
• 238000002360 preparation method Methods 0.000 description 7
• 238000012163 sequencing technique Methods 0.000 description 7
• 239000000243 solution Substances 0.000 description 7
• 102000014914 Carrier Proteins Human genes 0.000 description 6
• 108090000538 Caspase-8 Proteins 0.000 description 6
• 102000053602 DNA Human genes 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 6
• 230000000840 anti-viral effect Effects 0.000 description 6
• 230000000890 antigenic effect Effects 0.000 description 6
• 230000027455 binding Effects 0.000 description 6
• 108091008324 binding proteins Proteins 0.000 description 6
• 239000013592 cell lysate Substances 0.000 description 6
• 230000002950 deficient Effects 0.000 description 6
• 229940079322 interferon Drugs 0.000 description 6
• 229940100601 interleukin-6 Drugs 0.000 description 6
• 239000003550 marker Substances 0.000 description 6
• 230000026731 phosphorylation Effects 0.000 description 6
• 238000006366 phosphorylation reaction Methods 0.000 description 6
• 239000013641 positive control Substances 0.000 description 6
• 230000002829 reductive effect Effects 0.000 description 6
• 241000701161 unidentified adenovirus Species 0.000 description 6
• 230000001018 virulence Effects 0.000 description 6
• 101150023320 B16R gene Proteins 0.000 description 5
• 108091026890 Coding region Proteins 0.000 description 5
• 108020004705 Codon Proteins 0.000 description 5
• 241000701022 Cytomegalovirus Species 0.000 description 5
• 102000016911 Deoxyribonucleases Human genes 0.000 description 5
• 108010053770 Deoxyribonucleases Proteins 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• 108091006905 Human Serum Albumin Proteins 0.000 description 5
• 102000008100 Human Serum Albumin Human genes 0.000 description 5
• 108010010995 MART-1 Antigen Proteins 0.000 description 5
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 5
• 241000700562 Myxoma virus Species 0.000 description 5
• 108700005077 Viral Genes Proteins 0.000 description 5
• 230000033289 adaptive immune response Effects 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 239000002299 complementary DNA Substances 0.000 description 5
• 230000003247 decreasing effect Effects 0.000 description 5
• 150000002270 gangliosides Chemical class 0.000 description 5
• 238000001727 in vivo Methods 0.000 description 5
• 239000000411 inducer Substances 0.000 description 5
• 230000002458 infectious effect Effects 0.000 description 5
• 244000052769 pathogen Species 0.000 description 5
• 230000001717 pathogenic effect Effects 0.000 description 5
• 239000008055 phosphate buffer solution Substances 0.000 description 5
• 239000011780 sodium chloride Substances 0.000 description 5
• 235000002639 sodium chloride Nutrition 0.000 description 5
• 241000894007 species Species 0.000 description 5
• 208000024891 symptom Diseases 0.000 description 5
• 230000014616 translation Effects 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• 108020004463 18S ribosomal RNA Proteins 0.000 description 4
• 102100023635 Alpha-fetoprotein Human genes 0.000 description 4
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 4
• 241000894006 Bacteria Species 0.000 description 4
• 102100032912 CD44 antigen Human genes 0.000 description 4
• 108010009575 CD55 Antigens Proteins 0.000 description 4
• 102100022002 CD59 glycoprotein Human genes 0.000 description 4
• 241001137864 Camelpox virus Species 0.000 description 4
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 4
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 4
• 102000004091 Caspase-8 Human genes 0.000 description 4
• 102000011022 Chorionic Gonadotropin Human genes 0.000 description 4
• 108010062540 Chorionic Gonadotropin Proteins 0.000 description 4
• 101100233978 Cowpox virus (strain GRI-90 / Grishak) KBTB2 gene Proteins 0.000 description 4
• 241000725630 Ectromelia virus Species 0.000 description 4
• 241000700572 Entomopoxvirinae Species 0.000 description 4
• 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 4
• 102000003956 Fibroblast growth factor 8 Human genes 0.000 description 4
• 102400000921 Gastrin Human genes 0.000 description 4
• 241000224467 Giardia intestinalis Species 0.000 description 4
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 4
• 102000005720 Glutathione transferase Human genes 0.000 description 4
• 108010070675 Glutathione transferase Proteins 0.000 description 4
• 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 4
• 241000724675 Hepatitis E virus Species 0.000 description 4
• 208000037262 Hepatitis delta Diseases 0.000 description 4
• 241000724709 Hepatitis delta virus Species 0.000 description 4
• 241000709721 Hepatovirus A Species 0.000 description 4
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 4
• 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 4
• 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 description 4
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 4
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 4
• 241000725303 Human immunodeficiency virus Species 0.000 description 4
• 241000701806 Human papillomavirus Species 0.000 description 4
• 102100040019 Interferon alpha-1/13 Human genes 0.000 description 4
• 108010017511 Interleukin-13 Receptors Proteins 0.000 description 4
• 102100039078 Interleukin-4 receptor subunit alpha Human genes 0.000 description 4
• 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 4
• 102000018697 Membrane Proteins Human genes 0.000 description 4
• 108010052285 Membrane Proteins Proteins 0.000 description 4
• 102100039373 Membrane cofactor protein Human genes 0.000 description 4
• 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 description 4
• 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 description 4
• 241000725643 Respiratory syncytial virus Species 0.000 description 4
• 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 4
• 241000404000 Tanapox virus Species 0.000 description 4
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 4
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 4
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
• 101100004100 Vaccinia virus (strain Western Reserve) VACWR199 gene Proteins 0.000 description 4
• 241000587120 Vaccinia virus Ankara Species 0.000 description 4
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 4
• 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 4
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 4
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 4
• 208000036142 Viral infection Diseases 0.000 description 4
• 102000012740 beta Adrenergic Receptors Human genes 0.000 description 4
• 108010079452 beta Adrenergic Receptors Proteins 0.000 description 4
• 230000014564 chemokine production Effects 0.000 description 4
• 201000003740 cowpox Diseases 0.000 description 4
• 230000016396 cytokine production Effects 0.000 description 4
• 210000000805 cytoplasm Anatomy 0.000 description 4
• 238000001514 detection method Methods 0.000 description 4
• 239000012895 dilution Substances 0.000 description 4
• 238000010790 dilution Methods 0.000 description 4
• 239000003814 drug Substances 0.000 description 4
• 239000012530 fluid Substances 0.000 description 4
• XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 4
• 229940035638 gonadotropin-releasing hormone Drugs 0.000 description 4
• 230000012010 growth Effects 0.000 description 4
• 229940084986 human chorionic gonadotropin Drugs 0.000 description 4
• 210000004698 lymphocyte Anatomy 0.000 description 4
• 210000001161 mammalian embryo Anatomy 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 230000035772 mutation Effects 0.000 description 4
• 102000040430 polynucleotide Human genes 0.000 description 4
• 108091033319 polynucleotide Proteins 0.000 description 4
• 239000002157 polynucleotide Substances 0.000 description 4
• 230000002265 prevention Effects 0.000 description 4
• 230000006798 recombination Effects 0.000 description 4
• 238000005215 recombination Methods 0.000 description 4
• 108020004418 ribosomal RNA Proteins 0.000 description 4
• 239000000126 substance Substances 0.000 description 4
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 4
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 4
• 241001529453 unidentified herpesvirus Species 0.000 description 4
• 230000029812 viral genome replication Effects 0.000 description 4
• 230000009385 viral infection Effects 0.000 description 4
• 239000013603 viral vector Substances 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• 102100037435 Antiviral innate immune response receptor RIG-I Human genes 0.000 description 3
• 101710127675 Antiviral innate immune response receptor RIG-I Proteins 0.000 description 3
• 206010006187 Breast cancer Diseases 0.000 description 3
• 208000026310 Breast neoplasm Diseases 0.000 description 3
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 3
• 230000004543 DNA replication Effects 0.000 description 3
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 3
• 241000711549 Hepacivirus C Species 0.000 description 3
• 101710090028 Inositol-3-phosphate synthase 1 Proteins 0.000 description 3
• 102100027353 Interferon-induced helicase C domain-containing protein 1 Human genes 0.000 description 3
• 101710085994 Interferon-induced helicase C domain-containing protein 1 Proteins 0.000 description 3
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
• 102100023727 Mitochondrial antiviral-signaling protein Human genes 0.000 description 3
• 101710142315 Mitochondrial antiviral-signaling protein Proteins 0.000 description 3
• 241000233872 Pneumocystis carinii Species 0.000 description 3
• 241000142787 Pneumocystis jirovecii Species 0.000 description 3
• 241000607142 Salmonella Species 0.000 description 3
• 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 3
• 241000700565 Swinepox virus Species 0.000 description 3
• 108091008874 T cell receptors Proteins 0.000 description 3
• 230000005867 T cell response Effects 0.000 description 3
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 3
• 238000011053 TCID50 method Methods 0.000 description 3
• 241000375392 Tana Species 0.000 description 3
• 102400001320 Transforming growth factor alpha Human genes 0.000 description 3
• 101800004564 Transforming growth factor alpha Proteins 0.000 description 3
• 239000007983 Tris buffer Substances 0.000 description 3
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• 230000006907 apoptotic process Effects 0.000 description 3
• 238000003556 assay Methods 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 108010005774 beta-Galactosidase Proteins 0.000 description 3
• 210000001185 bone marrow Anatomy 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 239000003795 chemical substances by application Substances 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 230000004069 differentiation Effects 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 239000012636 effector Substances 0.000 description 3
• 238000000684 flow cytometry Methods 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 235000011187 glycerol Nutrition 0.000 description 3
• 210000002443 helper t lymphocyte Anatomy 0.000 description 3
• 210000000987 immune system Anatomy 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 238000003780 insertion Methods 0.000 description 3
• 230000037431 insertion Effects 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 239000013612 plasmid Substances 0.000 description 3
• 239000000047 product Substances 0.000 description 3
• 230000000644 propagated effect Effects 0.000 description 3
• 230000001850 reproductive effect Effects 0.000 description 3
• 230000000717 retained effect Effects 0.000 description 3
• 230000002441 reversible effect Effects 0.000 description 3
• 230000011664 signaling Effects 0.000 description 3
• 238000003860 storage Methods 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 230000009885 systemic effect Effects 0.000 description 3
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
• NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 description 2
• LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 2
• WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 description 2
• 101800000504 3C-like protease Proteins 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
• 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 2
• 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 2
• 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 2
• 102100036464 Activated RNA polymerase II transcriptional coactivator p15 Human genes 0.000 description 2
• 102100021305 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Human genes 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• 102000052587 Anaphase-Promoting Complex-Cyclosome Apc3 Subunit Human genes 0.000 description 2
• 108700004606 Anaphase-Promoting Complex-Cyclosome Apc3 Subunit Proteins 0.000 description 2
• 241000244023 Anisakis Species 0.000 description 2
• 241000228193 Aspergillus clavatus Species 0.000 description 2
• 241000228197 Aspergillus flavus Species 0.000 description 2
• 241001225321 Aspergillus fumigatus Species 0.000 description 2
• 241000351920 Aspergillus nidulans Species 0.000 description 2
• 241000228245 Aspergillus niger Species 0.000 description 2
• 241001465318 Aspergillus terreus Species 0.000 description 2
• 101710187595 B-cell receptor CD22 Proteins 0.000 description 2
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 2
• 241000223836 Babesia Species 0.000 description 2
• 241000193738 Bacillus anthracis Species 0.000 description 2
• 241000244183 Baylisascaris procyonis Species 0.000 description 2
• 102000015735 Beta-catenin Human genes 0.000 description 2
• 108060000903 Beta-catenin Proteins 0.000 description 2
• 241000588832 Bordetella pertussis Species 0.000 description 2
• 241000589969 Borreliella burgdorferi Species 0.000 description 2
• 241000621124 Bovine papular stomatitis virus Species 0.000 description 2
• 241000589567 Brucella abortus Species 0.000 description 2
• 241001509299 Brucella canis Species 0.000 description 2
• 241001148106 Brucella melitensis Species 0.000 description 2
• 241001148111 Brucella suis Species 0.000 description 2
• 102100024217 CAMPATH-1 antigen Human genes 0.000 description 2
• 108091016585 CD44 antigen Proteins 0.000 description 2
• 108010065524 CD52 Antigen Proteins 0.000 description 2
• 108010055167 CD59 Antigens Proteins 0.000 description 2
• 101150108242 CDC27 gene Proteins 0.000 description 2
• MUJJVOYNTCTXIC-UHFFFAOYSA-N CNC(=O)c1ccc2-c3c(C)c(nn3CCOc2c1)-c1ncnn1-c1ccc(F)cc1F Chemical compound CNC(=O)c1ccc2-c3c(C)c(nn3CCOc2c1)-c1ncnn1-c1ccc(F)cc1F MUJJVOYNTCTXIC-UHFFFAOYSA-N 0.000 description 2
• 241000589875 Campylobacter jejuni Species 0.000 description 2
• 102100025570 Cancer/testis antigen 1 Human genes 0.000 description 2
• 241000222178 Candida tropicalis Species 0.000 description 2
• 102100024423 Carbonic anhydrase 9 Human genes 0.000 description 2
• 102100026548 Caspase-8 Human genes 0.000 description 2
• 102000005600 Cathepsins Human genes 0.000 description 2
• 108010084457 Cathepsins Proteins 0.000 description 2
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 2
• 241000282693 Cercopithecidae Species 0.000 description 2
• 241000282985 Cervus Species 0.000 description 2
• 241000606161 Chlamydia Species 0.000 description 2
• 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 2
• 241000193163 Clostridioides difficile Species 0.000 description 2
• 241000193468 Clostridium perfringens Species 0.000 description 2
• 241000193449 Clostridium tetani Species 0.000 description 2
• 206010009944 Colon cancer Diseases 0.000 description 2
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
• 102100025680 Complement decay-accelerating factor Human genes 0.000 description 2
• 102100030886 Complement receptor type 1 Human genes 0.000 description 2
• 102100032768 Complement receptor type 2 Human genes 0.000 description 2
• 108020004635 Complementary DNA Proteins 0.000 description 2
• 241000186216 Corynebacterium Species 0.000 description 2
• 241000709687 Coxsackievirus Species 0.000 description 2
• 241000150230 Crimean-Congo hemorrhagic fever orthonairovirus Species 0.000 description 2
• 201000007336 Cryptococcosis Diseases 0.000 description 2
• 241001522864 Cryptococcus gattii VGI Species 0.000 description 2
• 241000221204 Cryptococcus neoformans Species 0.000 description 2
• 241000223935 Cryptosporidium Species 0.000 description 2
• 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 2
• 102000009508 Cyclin-Dependent Kinase Inhibitor p16 Human genes 0.000 description 2
• 108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 description 2
• 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 2
• 108010037462 Cyclooxygenase 2 Proteins 0.000 description 2
• 241000016605 Cyclospora cayetanensis Species 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• 241000725619 Dengue virus Species 0.000 description 2
• 101100216227 Dictyostelium discoideum anapc3 gene Proteins 0.000 description 2
• 241001137876 Diphyllobothrium Species 0.000 description 2
• 241001319090 Dracunculus medinensis Species 0.000 description 2
• 101710201734 E3 protein Proteins 0.000 description 2
• 101150049307 EEF1A2 gene Proteins 0.000 description 2
• 101150029707 ERBB2 gene Proteins 0.000 description 2
• 241001115402 Ebolavirus Species 0.000 description 2
• 241000224432 Entamoeba histolytica Species 0.000 description 2
• 241000194032 Enterococcus faecalis Species 0.000 description 2
• 241000194031 Enterococcus faecium Species 0.000 description 2
• 241000709661 Enterovirus Species 0.000 description 2
• 102400000102 Eosinophil granule major basic protein Human genes 0.000 description 2
• 241000588722 Escherichia Species 0.000 description 2
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
• 102000007317 Farnesyltranstransferase Human genes 0.000 description 2
• 108010007508 Farnesyltranstransferase Proteins 0.000 description 2
• 101710113436 GTPase KRas Proteins 0.000 description 2
• 102100039788 GTPase NRas Human genes 0.000 description 2
• 108010052343 Gastrins Proteins 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 241001112691 Goatpox virus Species 0.000 description 2
• 102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 description 2
• 108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 description 2
• 108010022901 Heparin Lyase Proteins 0.000 description 2
• 241000700721 Hepatitis B virus Species 0.000 description 2
• 241000228404 Histoplasma capsulatum Species 0.000 description 2
• 101001042227 Homo sapiens Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Proteins 0.000 description 2
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 2
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 2
• 101100165850 Homo sapiens CA9 gene Proteins 0.000 description 2
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 2
• 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 2
• 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 2
• 101000856022 Homo sapiens Complement decay-accelerating factor Proteins 0.000 description 2
• 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 description 2
• 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 description 2
• 101000744505 Homo sapiens GTPase NRas Proteins 0.000 description 2
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 2
• 101001014223 Homo sapiens MAPK/MAK/MRK overlapping kinase Proteins 0.000 description 2
• 101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 description 2
• 101000623901 Homo sapiens Mucin-16 Proteins 0.000 description 2
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 2
• 101000693231 Homo sapiens PDZK1-interacting protein 1 Proteins 0.000 description 2
• 101001062222 Homo sapiens Receptor-binding cancer antigen expressed on SiSo cells Proteins 0.000 description 2
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
• 101000626112 Homo sapiens Telomerase protein component 1 Proteins 0.000 description 2
• 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 2
• 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 2
• 101000597785 Homo sapiens Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 2
• 101000818517 Homo sapiens Zinc-alpha-2-glycoprotein Proteins 0.000 description 2
• 241000701074 Human alphaherpesvirus 2 Species 0.000 description 2
• 241000342334 Human metapneumovirus Species 0.000 description 2
• 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 2
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
• 102000014429 Insulin-like growth factor Human genes 0.000 description 2
• 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 description 2
• 101710148794 Intercellular adhesion molecule 2 Proteins 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• 241000712890 Junin mammarenavirus Species 0.000 description 2
• 102100031413 L-dopachrome tautomerase Human genes 0.000 description 2
• 101710093778 L-dopachrome tautomerase Proteins 0.000 description 2
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 241000712902 Lassa mammarenavirus Species 0.000 description 2
• 241000186779 Listeria monocytogenes Species 0.000 description 2
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 2
• 241000609846 Lumpy skin disease virus Species 0.000 description 2
• 102100031520 MAPK/MAK/MRK overlapping kinase Human genes 0.000 description 2
• 102000043129 MHC class I family Human genes 0.000 description 2
• 108091054437 MHC class I family Proteins 0.000 description 2
• 241000712898 Machupo mammarenavirus Species 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• 241001115401 Marburgvirus Species 0.000 description 2
• 241000712079 Measles morbillivirus Species 0.000 description 2
• 102000051089 Melanotransferrin Human genes 0.000 description 2
• 108700038051 Melanotransferrin Proteins 0.000 description 2
• 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 2
• 201000009906 Meningitis Diseases 0.000 description 2
• 102000003735 Mesothelin Human genes 0.000 description 2
• 108090000015 Mesothelin Proteins 0.000 description 2
• 102000036436 Metzincins Human genes 0.000 description 2
• 108091007161 Metzincins Proteins 0.000 description 2
• 241000893980 Microsporum canis Species 0.000 description 2
• 102100023123 Mucin-16 Human genes 0.000 description 2
• 108010063954 Mucins Proteins 0.000 description 2
• 241000711386 Mumps virus Species 0.000 description 2
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 2
• 241000186362 Mycobacterium leprae Species 0.000 description 2
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
• 241000202934 Mycoplasma pneumoniae Species 0.000 description 2
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 2
• OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
• OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 2
• MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
• 102000012064 NLR Proteins Human genes 0.000 description 2
• 108091005686 NOD-like receptors Proteins 0.000 description 2
• 241001443590 Naganishia albida Species 0.000 description 2
• 241000588653 Neisseria Species 0.000 description 2
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 2
• 241000714209 Norwalk virus Species 0.000 description 2
• 241000700635 Orf virus Species 0.000 description 2
• 241001638394 Orphe Species 0.000 description 2
• 102000009890 Osteonectin Human genes 0.000 description 2
• 108010077077 Osteonectin Proteins 0.000 description 2
• 102100025648 PDZK1-interacting protein 1 Human genes 0.000 description 2
• 108060006580 PRAME Proteins 0.000 description 2
• 102000036673 PRAME Human genes 0.000 description 2
• 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 2
• 102000005891 Pancreatic ribonuclease Human genes 0.000 description 2
• 241000222051 Papiliotrema laurentii Species 0.000 description 2
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
• 239000001888 Peptone Substances 0.000 description 2
• 108010080698 Peptones Proteins 0.000 description 2
• 241000700667 Pigeonpox virus Species 0.000 description 2
• 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 2
• 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 2
• 208000000474 Poliomyelitis Diseases 0.000 description 2
• 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
• 241000125945 Protoparvovirus Species 0.000 description 2
• 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
• 241000569181 Quailpox virus Species 0.000 description 2
• 239000013614 RNA sample Substances 0.000 description 2
• 241000700564 Rabbit fibroma virus Species 0.000 description 2
• 241000711798 Rabies lyssavirus Species 0.000 description 2
• 241000700638 Raccoonpox virus Species 0.000 description 2
• 102100029165 Receptor-binding cancer antigen expressed on SiSo cells Human genes 0.000 description 2
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
• 108010046983 Ribonuclease T1 Proteins 0.000 description 2
• 241000606701 Rickettsia Species 0.000 description 2
• 241000702670 Rotavirus Species 0.000 description 2
• 241000710799 Rubella virus Species 0.000 description 2
• 108091077753 SSX family Proteins 0.000 description 2
• 102000042330 SSX family Human genes 0.000 description 2
• 108010017324 STAT3 Transcription Factor Proteins 0.000 description 2
• 241000192617 Sabia mammarenavirus Species 0.000 description 2
• 241000287219 Serinus canaria Species 0.000 description 2
• 101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 2
• 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 2
• 102100024040 Signal transducer and activator of transcription 3 Human genes 0.000 description 2
• 241001147691 Staphylococcus saprophyticus Species 0.000 description 2
• 108091081024 Start codon Proteins 0.000 description 2
• 241000193985 Streptococcus agalactiae Species 0.000 description 2
• 241000193998 Streptococcus pneumoniae Species 0.000 description 2
• 241000193996 Streptococcus pyogenes Species 0.000 description 2
• 238000000692 Student's t-test Methods 0.000 description 2
• 230000006044 T cell activation Effects 0.000 description 2
• 230000024932 T cell mediated immunity Effects 0.000 description 2
• 101710109927 Tail assembly protein GT Proteins 0.000 description 2
• 102100024553 Telomerase protein component 1 Human genes 0.000 description 2
• 108020005038 Terminator Codon Proteins 0.000 description 2
• 208000007712 Tinea Versicolor Diseases 0.000 description 2
• 206010043871 Tinea nigra Diseases 0.000 description 2
• 206010056131 Tinea versicolour Diseases 0.000 description 2
• 102000002689 Toll-like receptor Human genes 0.000 description 2
• 108020000411 Toll-like receptor Proteins 0.000 description 2
• 102100024324 Toll-like receptor 3 Human genes 0.000 description 2
• 102100039390 Toll-like receptor 7 Human genes 0.000 description 2
• 241000223997 Toxoplasma gondii Species 0.000 description 2
• 108091023040 Transcription factor Proteins 0.000 description 2
• 102000040945 Transcription factor Human genes 0.000 description 2
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 2
• 102000004357 Transferases Human genes 0.000 description 2
• 108090000992 Transferases Proteins 0.000 description 2
• 102100026145 Transitional endoplasmic reticulum ATPase Human genes 0.000 description 2
• 241000589884 Treponema pallidum Species 0.000 description 2
• 241000243777 Trichinella spiralis Species 0.000 description 2
• 241000223229 Trichophyton rubrum Species 0.000 description 2
• 241001480048 Trichophyton tonsurans Species 0.000 description 2
• LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 2
• 241000223109 Trypanosoma cruzi Species 0.000 description 2
• 102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 2
• 102000003425 Tyrosinase Human genes 0.000 description 2
• 108060008724 Tyrosinase Proteins 0.000 description 2
• 102100027244 U4/U6.U5 tri-snRNP-associated protein 1 Human genes 0.000 description 2
• 101710155955 U4/U6.U5 tri-snRNP-associated protein 1 Proteins 0.000 description 2
• LFTYTUAZOPRMMI-CFRASDGPSA-N UDP-N-acetyl-alpha-D-glucosamine Chemical compound O1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-CFRASDGPSA-N 0.000 description 2
• LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 description 2
• 101900302314 Vaccinia virus A-type inclusion protein A25 Proteins 0.000 description 2
• 241000607626 Vibrio cholerae Species 0.000 description 2
• 108020005202 Viral DNA Proteins 0.000 description 2
• 241000710886 West Nile virus Species 0.000 description 2
• 241000710772 Yellow fever virus Species 0.000 description 2
• 241000607479 Yersinia pestis Species 0.000 description 2
• 108010084455 Zeocin Proteins 0.000 description 2
• 102100021144 Zinc-alpha-2-glycoprotein Human genes 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 230000008649 adaptation response Effects 0.000 description 2
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
• 125000000539 amino acid group Chemical group 0.000 description 2
• 210000004102 animal cell Anatomy 0.000 description 2
• 210000000612 antigen-presenting cell Anatomy 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 229940091771 aspergillus fumigatus Drugs 0.000 description 2
• 201000008680 babesiosis Diseases 0.000 description 2
• 229940065181 bacillus anthracis Drugs 0.000 description 2
• 239000003855 balanced salt solution Substances 0.000 description 2
• 230000006399 behavior Effects 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 229940056450 brucella abortus Drugs 0.000 description 2
• 229940038698 brucella melitensis Drugs 0.000 description 2
• 238000010804 cDNA synthesis Methods 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 210000003711 chorioallantoic membrane Anatomy 0.000 description 2
• 150000001875 compounds Chemical class 0.000 description 2
• 238000012937 correction Methods 0.000 description 2
• 239000012228 culture supernatant Substances 0.000 description 2
• 210000004748 cultured cell Anatomy 0.000 description 2
• 239000008121 dextrose Substances 0.000 description 2
• 241001493065 dsRNA viruses Species 0.000 description 2
• 210000002257 embryonic structure Anatomy 0.000 description 2
• 239000003995 emulsifying agent Substances 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 229940007078 entamoeba histolytica Drugs 0.000 description 2
• 229940032049 enterococcus faecalis Drugs 0.000 description 2
• 230000000369 enteropathogenic effect Effects 0.000 description 2
• 230000000688 enterotoxigenic effect Effects 0.000 description 2
• 108010048134 estramustine-binding protein Proteins 0.000 description 2
• 108020005243 folate receptor Proteins 0.000 description 2
• 102000006815 folate receptor Human genes 0.000 description 2
• 108010066264 gastrin 17 Proteins 0.000 description 2
• GKDWRERMBNGKCZ-RNXBIMIWSA-N gastrin-17 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 GKDWRERMBNGKCZ-RNXBIMIWSA-N 0.000 description 2
• 238000003633 gene expression assay Methods 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• 230000007124 immune defense Effects 0.000 description 2
• 238000003119 immunoblot Methods 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 238000011081 inoculation Methods 0.000 description 2
• 239000002054 inoculum Substances 0.000 description 2
• 229960000318 kanamycin Drugs 0.000 description 2
• 229930027917 kanamycin Natural products 0.000 description 2
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
• 229930182823 kanamycin A Natural products 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 231100000518 lethal Toxicity 0.000 description 2
• 230000001665 lethal effect Effects 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 210000004379 membrane Anatomy 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 229950006780 n-acetylglucosamine Drugs 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• 238000012261 overproduction Methods 0.000 description 2
• 101800000607 p15 Proteins 0.000 description 2
• 239000006179 pH buffering agent Substances 0.000 description 2
• 230000003071 parasitic effect Effects 0.000 description 2
• 230000007918 pathogenicity Effects 0.000 description 2
• 235000019319 peptone Nutrition 0.000 description 2
• 230000002085 persistent effect Effects 0.000 description 2
• CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 2
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 239000003755 preservative agent Substances 0.000 description 2
• 238000003753 real-time PCR Methods 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 239000003488 releasing hormone Substances 0.000 description 2
• 210000002966 serum Anatomy 0.000 description 2
• 238000004904 shortening Methods 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 210000000952 spleen Anatomy 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 238000010186 staining Methods 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 101150050955 stn gene Proteins 0.000 description 2
• 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
• 101150047061 tag-72 gene Proteins 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 210000001550 testis Anatomy 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 229940096911 trichinella spiralis Drugs 0.000 description 2
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
• 241000712461 unidentified influenza virus Species 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• 229940118696 vibrio cholerae Drugs 0.000 description 2
• 230000006648 viral gene expression Effects 0.000 description 2
• 230000006490 viral transcription Effects 0.000 description 2
• 230000004580 weight loss Effects 0.000 description 2
• 238000009736 wetting Methods 0.000 description 2
• 239000000080 wetting agent Substances 0.000 description 2
• 229940051021 yellow-fever virus Drugs 0.000 description 2
• 108020005345 3' Untranslated Regions Proteins 0.000 description 1
• XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
• 229940124965 ACAM2000 Drugs 0.000 description 1
• 102100022410 ATP-dependent DNA/RNA helicase DHX36 Human genes 0.000 description 1
• 102100021405 ATP-dependent RNA helicase DDX1 Human genes 0.000 description 1
• 206010001197 Adenocarcinoma of the cervix Diseases 0.000 description 1
• 208000034246 Adenocarcinoma of the cervix uteri Diseases 0.000 description 1
• 206010067484 Adverse reaction Diseases 0.000 description 1
• 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
• VJVQKGYHIZPSNS-FXQIFTODSA-N Ala-Ser-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N VJVQKGYHIZPSNS-FXQIFTODSA-N 0.000 description 1
• 241000877350 Alphaentomopoxvirus Species 0.000 description 1
• 101710145634 Antigen 1 Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• HCAUEJAQCXVQQM-ACZMJKKPSA-N Asn-Glu-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HCAUEJAQCXVQQM-ACZMJKKPSA-N 0.000 description 1
• 206010003757 Atypical pneumonia Diseases 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 101150067954 B15R gene Proteins 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 241000700576 Betaentomopoxvirus Species 0.000 description 1
• 241000228405 Blastomyces dermatitidis Species 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 101150071146 COX2 gene Proteins 0.000 description 1
• 101100114534 Caenorhabditis elegans ctc-2 gene Proteins 0.000 description 1
• 241000178270 Canarypox virus Species 0.000 description 1
• 241001647378 Chlamydia psittaci Species 0.000 description 1
• 108091033380 Coding strand Proteins 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• WCZDQPXNBJTKPI-UHFFFAOYSA-O Cyanidin 7-glucoside Chemical compound OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C(C=C(O)C(=[O+]2)C=3C=C(O)C(O)=CC=3)C2=C1 WCZDQPXNBJTKPI-UHFFFAOYSA-O 0.000 description 1
• UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 241000222175 Diutina rugosa Species 0.000 description 1
• 102100031780 Endonuclease Human genes 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 102000001690 Factor VIII Human genes 0.000 description 1
• 108010054218 Factor VIII Proteins 0.000 description 1
• 206010017533 Fungal infection Diseases 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 108091072337 GAGE family Proteins 0.000 description 1
• 102000040452 GAGE family Human genes 0.000 description 1
• CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 206010019799 Hepatitis viral Diseases 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• RXVOMIADLXPJGW-GUBZILKMSA-N His-Asp-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RXVOMIADLXPJGW-GUBZILKMSA-N 0.000 description 1
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
• 101000901942 Homo sapiens ATP-dependent DNA/RNA helicase DHX36 Proteins 0.000 description 1
• 101001041697 Homo sapiens ATP-dependent RNA helicase DDX1 Proteins 0.000 description 1
• 101000953492 Homo sapiens Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 Proteins 0.000 description 1
• 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
• 101001054334 Homo sapiens Interferon beta Proteins 0.000 description 1
• 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 description 1
• 101000912678 Homo sapiens Nucleolar RNA helicase 2 Proteins 0.000 description 1
• 101000633613 Homo sapiens Probable threonine protease PRSS50 Proteins 0.000 description 1
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
• 101001052849 Homo sapiens Tyrosine-protein kinase Fer Proteins 0.000 description 1
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
• 101100321817 Human parvovirus B19 (strain HV) 7.5K gene Proteins 0.000 description 1
• DOMWKUIIPQCAJU-LJHIYBGHSA-N Hydroxyprogesterone caproate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)CCCCC)[C@@]1(C)CC2 DOMWKUIIPQCAJU-LJHIYBGHSA-N 0.000 description 1
• 108700002232 Immediate-Early Genes Proteins 0.000 description 1
• 102100037739 Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 Human genes 0.000 description 1
• 102100025390 Integrin beta-2 Human genes 0.000 description 1
• 108010086140 Interferon alpha-beta Receptor Proteins 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
• 241000589242 Legionella pneumophila Species 0.000 description 1
• 241000589929 Leptospira interrogans Species 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
• 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 description 1
• NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 102000016200 MART-1 Antigen Human genes 0.000 description 1
• 102000043131 MHC class II family Human genes 0.000 description 1
• 108091054438 MHC class II family Proteins 0.000 description 1
• 206010026749 Mania Diseases 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 108060004795 Methyltransferase Proteins 0.000 description 1
• 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 1
• 101000746372 Mus musculus Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 1
• 101001054328 Mus musculus Interferon beta Proteins 0.000 description 1
• 101100481581 Mus musculus Tlr13 gene Proteins 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• 108091061960 Naked DNA Proteins 0.000 description 1
• 241001045988 Neogene Species 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 101150000187 PTGS2 gene Proteins 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
• 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
• PYOHODCEOHCZBM-RYUDHWBXSA-N Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 PYOHODCEOHCZBM-RYUDHWBXSA-N 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 241001066068 Pneumia Species 0.000 description 1
• 241000233870 Pneumocystis Species 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 229920000954 Polyglycolide Polymers 0.000 description 1
• 241000700625 Poxviridae Species 0.000 description 1
• 208000005585 Poxviridae Infections Diseases 0.000 description 1
• 241000677647 Proba Species 0.000 description 1
• 102100037427 Probable ATP-dependent RNA helicase DDX56 Human genes 0.000 description 1
• 102100029523 Probable threonine protease PRSS50 Human genes 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 238000010240 RT-PCR analysis Methods 0.000 description 1
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
• 108020005091 Replication Origin Proteins 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 241000315672 SARS coronavirus Species 0.000 description 1
• 101150071286 SPI-2 gene Proteins 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 241000607760 Shigella sonnei Species 0.000 description 1
• 241000710960 Sindbis virus Species 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 241000191963 Staphylococcus epidermidis Species 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• GQPQJNMVELPZNQ-GBALPHGKSA-N Thr-Ser-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O GQPQJNMVELPZNQ-GBALPHGKSA-N 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 206010067719 Tinea faciei Diseases 0.000 description 1
• 206010043870 Tinea infections Diseases 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 102000004243 Tubulin Human genes 0.000 description 1
• 108090000704 Tubulin Proteins 0.000 description 1
• LUMQYLVYUIRHHU-YJRXYDGGSA-N Tyr-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LUMQYLVYUIRHHU-YJRXYDGGSA-N 0.000 description 1
• FZADUTOCSFDBRV-RNXOBYDBSA-N Tyr-Tyr-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=C(O)C=C1 FZADUTOCSFDBRV-RNXOBYDBSA-N 0.000 description 1
• 102100024537 Tyrosine-protein kinase Fer Human genes 0.000 description 1
• 206010046861 Vaccination complication Diseases 0.000 description 1
• 101100534084 Vaccinia virus (strain Copenhagen) B14R gene Proteins 0.000 description 1
• 101100316834 Vaccinia virus (strain Copenhagen) B20R gene Proteins 0.000 description 1
• 101100004092 Vaccinia virus (strain Western Reserve) VACWR196 gene Proteins 0.000 description 1
• 101900001372 Vaccinia virus RNA-binding protein E3 Proteins 0.000 description 1
• 241000881059 Vaccinia virus Wyeth Species 0.000 description 1
• 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 description 1
• 108010067390 Viral Proteins Proteins 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 241001536558 Yaba monkey tumor virus Species 0.000 description 1
• SIIZPVYVXNXXQG-KGXOGWRBSA-N [(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-4-[[(3s,4r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-hydroxyoxolan-2-yl]methyl [(2r,4r,5r)-2-(6-aminopurin-9-yl)-4-hydroxy-5-(phosphonooxymethyl)oxolan-3-yl] hydrogen phosphate Polymers C1=NC2=C(N)N=CN=C2N1[C@@H]1O[C@H](COP(O)(=O)OC2[C@@H](O[C@H](COP(O)(O)=O)[C@H]2O)N2C3=NC=NC(N)=C3N=C2)[C@@H](O)[C@H]1OP(O)(=O)OCC([C@@H](O)[C@H]1O)OC1N1C(N=CN=C2N)=C2N=C1 SIIZPVYVXNXXQG-KGXOGWRBSA-N 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000003044 adaptive effect Effects 0.000 description 1
• 238000007792 addition Methods 0.000 description 1
• 230000002730 additional effect Effects 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 230000006838 adverse reaction Effects 0.000 description 1
• 229940037003 alum Drugs 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 239000003708 ampul Substances 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 230000014102 antigen processing and presentation of exogenous peptide antigen via MHC class I Effects 0.000 description 1
• 230000008349 antigen-specific humoral response Effects 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 230000001640 apoptogenic effect Effects 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 108010062796 arginyllysine Proteins 0.000 description 1
• 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
• 230000000680 avirulence Effects 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000008512 biological response Effects 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 201000008873 bone osteosarcoma Diseases 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 239000012876 carrier material Substances 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• RDMOROXKXONCAL-UEKVPHQBSA-N cefroxadine Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)OC)C(O)=O)=CCC=CC1 RDMOROXKXONCAL-UEKVPHQBSA-N 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 230000007969 cellular immunity Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 201000006662 cervical adenocarcinoma Diseases 0.000 description 1
• 230000007012 clinical effect Effects 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 239000013068 control sample Substances 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
• 239000004062 cytokinin Substances 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000005860 defense response to virus Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 229910003460 diamond Inorganic materials 0.000 description 1
• 239000010432 diamond Substances 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 230000002500 effect on skin Effects 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 230000008029 eradication Effects 0.000 description 1
• 235000019441 ethanol Nutrition 0.000 description 1
• 239000012527 feed solution Substances 0.000 description 1
• 239000012894 fetal calf serum Substances 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 102000035122 glycosylated proteins Human genes 0.000 description 1
• 108091005608 glycosylated proteins Proteins 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 238000002744 homologous recombination Methods 0.000 description 1
• 230000006801 homologous recombination Effects 0.000 description 1
• 229920001519 homopolymer Polymers 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 239000002955 immunomodulating agent Substances 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 230000003308 immunostimulating effect Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 210000003000 inclusion body Anatomy 0.000 description 1
• 230000006882 induction of apoptosis Effects 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 230000004941 influx Effects 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 108010018844 interferon type III Proteins 0.000 description 1
• 229960001388 interferon-beta Drugs 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 229960003299 ketamine Drugs 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 229940115932 legionella pneumophila Drugs 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 238000001638 lipofection Methods 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 210000005210 lymphoid organ Anatomy 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 101150091879 neo gene Proteins 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 230000001613 neoplastic effect Effects 0.000 description 1
• 238000007474 nonparametric Mann- Whitney U test Methods 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 108700010766 orthopoxvirus proteins Proteins 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 238000003909 pattern recognition Methods 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 239000002504 physiological saline solution Substances 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 210000005134 plasmacytoid dendritic cell Anatomy 0.000 description 1
• 239000013600 plasmid vector Substances 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 229910052697 platinum Inorganic materials 0.000 description 1
• 201000000317 pneumocystosis Diseases 0.000 description 1
• 229920000747 poly(lactic acid) Polymers 0.000 description 1
• 229940115272 polyinosinic:polycytidylic acid Drugs 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 229940024231 poxvirus vaccine Drugs 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 108010042121 probasin Proteins 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000012846 protein folding Effects 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 238000004153 renaturation Methods 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 239000000523 sample Substances 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 229940115939 shigella sonnei Drugs 0.000 description 1
• 239000013605 shuttle vector Substances 0.000 description 1
• 239000002356 single layer Substances 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 229940083538 smallpox vaccine Drugs 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 239000008247 solid mixture Substances 0.000 description 1
• 229940035044 sorbitan monolaurate Drugs 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 210000004988 splenocyte Anatomy 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 108010044292 tryptophyltyrosine Proteins 0.000 description 1
• 230000010472 type I IFN response Effects 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 238000012762 unpaired Student’s t-test Methods 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 210000003501 vero cell Anatomy 0.000 description 1
• 230000006656 viral protein synthesis Effects 0.000 description 1
• 230000007419 viral reactivation Effects 0.000 description 1
• 210000002845 virion Anatomy 0.000 description 1
• 238000011816 wild-type C57Bl6 mouse Methods 0.000 description 1
• 238000002424 x-ray crystallography Methods 0.000 description 1
• BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
• 229960001600 xylazine Drugs 0.000 description 1